Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
about
Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.Social participation in patients with multiple sclerosis: correlations between disability and economic burden.Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.Cost of Illness of Multiple Sclerosis - A Systematic Review.Assessment of upper extremity function in multiple sclerosis: review and opinion.The indirect costs of multiple sclerosis: systematic review and meta-analysis.Social Cognitive Factors, Physical Activity, and Mobility Impairment in Adults with Multiple Sclerosis.Usability and acceptability by a younger and older user group regarding a mobile robot-supported gait rehabilitation system.Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers.Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?Effects of Muscle Function and Limb Loading Asymmetries on Gait and Balance in People With Multiple Sclerosis.
P2860
Q30275324-7DD80589-AE13-4415-BC35-A8D3EFC1D9F5Q33729957-79A3C5D8-6A78-4B0A-8A11-41CCC14C657BQ36032349-D7788007-D5AD-4649-A2EE-A23633776AC1Q36076087-3A1E0B50-A56E-41B2-9D31-5DF77B0E9321Q38258103-827311D3-DF5D-42D9-84D3-C13A1B503FCBQ38550252-F4A6B8C6-BF85-4025-953F-FF0BDB942B5FQ38597946-A4E29512-56A1-4FF4-B70E-6736FE33E086Q38658671-6706F71F-6802-4D12-B682-BA24E45F7CE8Q39141038-92283E91-A3C7-4C39-A948-33EED953D21AQ41812779-5A6F6CA2-35E4-4BA8-91F6-C34A419D76F3Q47576864-812A952C-D3DC-4E56-8B74-00C17B52F371Q47945489-97A261B6-EEE2-4446-B3EB-0165D4AB0D6BQ52985191-02247BF9-AFDB-4D03-BCFC-B90551081E92Q55023467-88C1C867-1B4A-4150-B5D6-AE3CC7651F98
P2860
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impact of mobility impairment ...... of life in multiple sclerosis.
@ast
Impact of mobility impairment ...... of life in multiple sclerosis.
@en
Impact of mobility impairment ...... of life in multiple sclerosis.
@nl
type
label
Impact of mobility impairment ...... of life in multiple sclerosis.
@ast
Impact of mobility impairment ...... of life in multiple sclerosis.
@en
Impact of mobility impairment ...... of life in multiple sclerosis.
@nl
prefLabel
Impact of mobility impairment ...... of life in multiple sclerosis.
@ast
Impact of mobility impairment ...... of life in multiple sclerosis.
@en
Impact of mobility impairment ...... of life in multiple sclerosis.
@nl
P2093
P2860
P1433
P1476
Impact of mobility impairment ...... of life in multiple sclerosis.
@en
P2093
Christine Kohn
Craig I Coleman
Matthew F Sidovar
Matthew S Roberts
P2860
P304
P356
10.1371/JOURNAL.PONE.0054756
P407
P577
2013-01-23T00:00:00Z